Latest news
The Novo Nordisk Foundation is going global on cardiometabolic disease.
One of the world’s largest foundations is directing more funding beyond Denmark and making obesity, diabetes and cardiovascular disease a central international priority. The investment could fill a dangerous gap in global health. It also raises a harder question: when public systems underfund chronic disease, how much influence should private philanthropy have over what gets…
Pregnancy complications demand long-term cardiovascular care
MENA’s cardiometabolic crisis is a stability issue
IPM Brief – Issue 10 | Proof Is Not Access
The Transplant Is Not the Finish Line
For Pompe Infants, Time Is the Comparator
Alzheimer’s Trials Still Measure Too Little, Too Late
Mpox Reached Guinea-Bissau. Stigma Must Not Win.
The Most Preventable Cause of Vision Loss May Still Be Smoking
Global cardiovascular policy shifts accelerate, but diverging strategies expose uneven progress
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.